Literature DB >> 2168396

Substrate- and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP.

M K Thomas1, S H Francis, J D Corbin.   

Abstract

A purified bovine lung cGMP-binding cGMP-specific phosphodiesterase (cG-BPDE) was rapidly phosphorylated by purified bovine lung cGMP-dependent protein kinase (cGK). Within a physiological concentration range, cGK catalyzed phosphorylation of cG-BPDE at a rate approximately 10 times greater than did equimolar concentrations of purified catalytic subunit of cAMP-dependent protein kinase (cAK). cG-BPDE was a poor substrate for either purified protein kinase C or Ca2+/calmodulin-dependent protein kinase II. Binding of cGMP to the cG-BPDE binding site was required for phosphorylation since (a) phosphorylation of cG-BPDE by the catalytic subunit of cAK was cGMP-dependent, (b) phosphorylation of cG-BPDE in the presence of a cGMP analog specific for activation of cGK was cGMP-dependent, and (c) occupation of the cG-BPDE hydrolytic site with competitive inhibitors did not produce the cGMP-dependent effect. cGMP-dependent phosphorylation of cG-BPDE by both cGK and cAK occurred at serine. Proteolytic digestion of cG-BPDE phosphorylated by either cGK or cAK revealed the same phosphopeptide pattern, suggesting that phosphorylation by the two kinases occurred at the same or adjacent site(s). Tryptic digestion of cG-BPDE phosphorylated by cGK and [gamma-32P]ATP produced a single major phosphopeptide of approximately 2 kDa with the following amino-terminal sequence: Lys-Ile-Ser-Ala-Ser-Glu-Phe-Asp-Arg-Pro-Leu-Arg- Radioactivity was released during the third cycle of Edman degradation. cG-BPDE is one of few specific in vitro cGK substrates of known function to be identified. Elevation of intracellular cGMP may cause phosphorylation of cG-BPDE by modulating the substrate site availability as well as by activating cGK. Such regulation would greatly increase the selectivity of the phosphorylation of cG-BPDE and would represent a unique mechanism of action of a cyclic nucleotide or other second messenger.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168396

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  PDE5 is converted to an activated state upon cGMP binding to the GAF A domain.

Authors:  Sergei D Rybalkin; Irina G Rybalkina; Masami Shimizu-Albergine; Xiao-Bo Tang; Joseph A Beavo
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

2.  The catalytic subunit of protein kinase A triggers activation of the type V cyclic GMP-specific phosphodiesterase from guinea-pig lung.

Authors:  F Burns; I W Rodger; N J Pyne
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

Review 3.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

4.  cGMP-Prkg1 signaling and Pde5 inhibition shelter cochlear hair cells and hearing function.

Authors:  Mirko Jaumann; Juliane Dettling; Martin Gubelt; Ulrike Zimmermann; Andrea Gerling; François Paquet-Durand; Susanne Feil; Stephan Wolpert; Christoph Franz; Ksenya Varakina; Hao Xiong; Niels Brandt; Stephanie Kuhn; Hyun-Soon Geisler; Karin Rohbock; Peter Ruth; Jens Schlossmann; Joachim Hütter; Peter Sandner; Robert Feil; Jutta Engel; Marlies Knipper; Lukas Rüttiger
Journal:  Nat Med       Date:  2012-01-22       Impact factor: 53.440

5.  Allosteric-site and catalytic-site ligand effects on PDE5 functions are associated with distinct changes in physical form of the enzyme.

Authors:  Jackie D Corbin; Roya Zoraghi; Sharron H Francis
Journal:  Cell Signal       Date:  2009-08-06       Impact factor: 4.315

6.  The unexpected evolution of basic science studies about cyclic nucleotide action into a treatment for erectile dysfunction.

Authors:  Jackie Corbin
Journal:  J Biol Chem       Date:  2014-12-11       Impact factor: 5.157

7.  Localization of angiotensin-II type 1(AT1) receptors on buffalo spermatozoa: AT1 receptor activation during capacitation triggers rise in cyclic AMP and calcium.

Authors:  Sivaram Vedantam; Rita Rani; Monica Garg; Suresh K Atreja
Journal:  Mol Biol Rep       Date:  2014-01-17       Impact factor: 2.316

8.  Prevention of PKG-1α Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation.

Authors:  Taishi Nakamura; Guangshuo Zhu; Mark J Ranek; Kristen Kokkonen-Simon; Manling Zhang; Grace E Kim; Kenichi Tsujita; David A Kass
Journal:  Circ Heart Fail       Date:  2018-03       Impact factor: 8.790

9.  Real-time monitoring the spatiotemporal dynamics of intracellular cGMP in vascular smooth muscle cells.

Authors:  Kara F Held; Wolfgang R Dostmann
Journal:  Methods Mol Biol       Date:  2013

Review 10.  ABCD of the phosphodiesterase family: interaction and differential activity in COPD.

Authors:  David M G Halpin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.